PL3006022T3 - Osmolity do leczenia wirusowych chorób układu oddechowego - Google Patents
Osmolity do leczenia wirusowych chorób układu oddechowegoInfo
- Publication number
- PL3006022T3 PL3006022T3 PL15189573T PL15189573T PL3006022T3 PL 3006022 T3 PL3006022 T3 PL 3006022T3 PL 15189573 T PL15189573 T PL 15189573T PL 15189573 T PL15189573 T PL 15189573T PL 3006022 T3 PL3006022 T3 PL 3006022T3
- Authority
- PL
- Poland
- Prior art keywords
- respiratory diseases
- osmolytes
- treatment
- viral respiratory
- viral
- Prior art date
Links
- 230000000065 osmolyte Effects 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 title abstract 2
- 230000003612 virological effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 208000028004 allergic respiratory disease Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000012873 virucide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007040615A DE102007040615A1 (de) | 2007-08-27 | 2007-08-27 | Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen |
| EP08801690A EP2200603B1 (de) | 2007-08-27 | 2008-08-25 | Osmolyte zur behandlung von allergisch bedingten atemwegserkrankungen |
| PCT/EP2008/006959 WO2009027069A2 (de) | 2007-08-27 | 2008-08-25 | Osmolyte zur behandlung von allergisch oder viral bedingten atemwegserkrankungen |
| EP11004754.5A EP2380569B1 (de) | 2007-08-27 | 2008-08-25 | Osmolyte zur Reduzierung der Nebenwirkungen von Steroiden oder Antihistaminika |
| EP15189573.7A EP3006022B1 (de) | 2007-08-27 | 2008-08-25 | Osmolyte zur behandlung von viral bedingten atemwegserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3006022T3 true PL3006022T3 (pl) | 2022-03-28 |
Family
ID=40298861
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11004754T PL2380569T3 (pl) | 2007-08-27 | 2008-08-25 | Osmolity do zmniejszania niepożądanych działań steroidów lub leków przeciwhistaminowych |
| PL08801690T PL2200603T3 (pl) | 2007-08-27 | 2008-08-25 | Osmolity do leczenia alergicznych chorób oddechowych |
| PL15189573T PL3006022T3 (pl) | 2007-08-27 | 2008-08-25 | Osmolity do leczenia wirusowych chorób układu oddechowego |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11004754T PL2380569T3 (pl) | 2007-08-27 | 2008-08-25 | Osmolity do zmniejszania niepożądanych działań steroidów lub leków przeciwhistaminowych |
| PL08801690T PL2200603T3 (pl) | 2007-08-27 | 2008-08-25 | Osmolity do leczenia alergicznych chorób oddechowych |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8765691B2 (pl) |
| EP (4) | EP2380569B1 (pl) |
| JP (1) | JP2010536904A (pl) |
| KR (1) | KR101638637B1 (pl) |
| AT (1) | ATE514422T1 (pl) |
| AU (1) | AU2008291302B2 (pl) |
| CA (2) | CA2942021C (pl) |
| DE (1) | DE102007040615A1 (pl) |
| DK (1) | DK2380569T3 (pl) |
| ES (3) | ES2902827T3 (pl) |
| HU (1) | HUE043920T2 (pl) |
| PL (3) | PL2380569T3 (pl) |
| PT (1) | PT2380569T (pl) |
| TR (1) | TR201908270T4 (pl) |
| WO (1) | WO2009027069A2 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1858519B1 (de) * | 2005-03-12 | 2013-02-20 | Bitop Aktiengesellschaft Für Biotechnische Optimierung | Ectoin und/oder hydroxyectoin zur prophylaxe und behandlung chronisch entzündlicher darmerkrankungen |
| DE102008036725B4 (de) * | 2008-08-07 | 2021-01-28 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung für die nasale Applikation |
| DE102008039231A1 (de) | 2008-08-22 | 2010-02-25 | Bitop Ag | Verwendung von Glucosylglycerol |
| DE102011113059A1 (de) * | 2011-09-09 | 2013-03-14 | Bitop Ag | Therapeutische Anwendungen von Ectoin |
| BR112014012463A2 (pt) | 2011-11-24 | 2017-06-06 | Otsuka Pharma Factory Inc | agente protetor para ceratoconjuntiva ou agente supressor para distúrbio ceratoconjuntival |
| DE102014116903A1 (de) * | 2014-08-18 | 2016-02-18 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Cineolhaltige Zusammensetzung für die nasale Applikation |
| DE102015121050A1 (de) * | 2015-12-03 | 2017-06-08 | Bitop Ag | Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben |
| DE102016125378A1 (de) * | 2016-12-22 | 2018-06-28 | Werner Schmidt | Zusammensetzung zur Behandlung von Erkältungskrankheiten |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4305936A (en) * | 1980-10-09 | 1981-12-15 | Dermik Laboratories | Topical corticosteroid formulations |
| DE3635522A1 (de) * | 1986-10-18 | 1988-04-28 | Euro Celtique Sa | Pharmazeutische zusammensetzung |
| FR2674434B1 (fr) * | 1991-03-27 | 1993-06-18 | Nativelle Sa Ets | Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation. |
| US5876780A (en) * | 1993-04-29 | 1999-03-02 | Cultor, Ltd. | Compositions for treating coccidiosis |
| US5880098A (en) | 1996-04-12 | 1999-03-09 | Pharmacia & Upjohn Aktiebolag | Therapeutic treatment |
| PT101887A (pt) * | 1996-06-28 | 1998-01-30 | Inst De Biolog Ex E Tecnologic | Utilizacao de 2-0- -manosilglicerato para termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de enzimas, outros componenetes celulares e celulas |
| US20010056068A1 (en) * | 1998-03-04 | 2001-12-27 | Kristof Chwalisz | Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives |
| AU750027B2 (en) * | 1998-08-01 | 2002-07-11 | Merck Patent Gmbh | Use of ectoine or ectoine derivatives in cosmetic formulations |
| KR20010099865A (ko) * | 1998-12-22 | 2001-11-09 | 프란시스 제이 메이어 | 기도 질병 치료용 화합물과 그의 치료 방법 및 기도약물의 전달 방법 |
| ES2204640T3 (es) * | 1999-06-12 | 2004-05-01 | Bitop Aktiengesellschaft Fur Biotechnische Optimierung | Preparado farmaceutico con contenido en proteinas. |
| ES2233630T3 (es) * | 2000-04-12 | 2005-06-16 | Bitop Aktiengesellschaft Fur Biotechnische Optimierung | Uso de solutos compatibles como sustancias con propiedades barredoras de radicales. |
| ES2336545T3 (es) | 2000-08-18 | 2010-04-14 | Bitop Gesellschaft Fur Biotechnische Optimierung Mbh | Empleo de fosfatos de alcoholes disacaricos para la proteccion de las celulas cutaneas humanas contra la irradiacion uv y/o ir. |
| DE10040933A1 (de) * | 2000-08-18 | 2002-03-07 | Bitop Gmbh | Verwendung von beta-Mannosylglycerat (Firoin) und/oder Derivaten, insbesondere dem beta-Mannosylglyceramid (Firoin-A), in kosmetischen und dermatologischen Formulierungen |
| DE10044985B4 (de) * | 2000-09-11 | 2019-08-14 | Merck Patent Gmbh | Verwendung von Ectoin oder Ectoin-Derivaten zum Schutz vor Allergenen |
| AU2001296770A1 (en) * | 2000-10-06 | 2002-04-15 | Durect Corporation | Devices and methods for management of inflammation |
| US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
| DE10330243A1 (de) | 2003-07-03 | 2005-01-20 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis |
| DE10330768A1 (de) * | 2003-07-07 | 2005-02-24 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung |
| JP4780907B2 (ja) * | 2003-09-30 | 2011-09-28 | 小林製薬株式会社 | 催眠剤組成物 |
| DE102004049062A1 (de) | 2004-03-30 | 2005-10-13 | bitop Aktiengesellschaft für biotechnische Optimierung | Topische Zubereitung zur Anwendung auf der Haut enthaltend natürliches Öl der Nachtkerze (Oenothera biennis) (=Oleum Oenothera) und Osmolyte aus extremophilen Mikroorganismen |
| EP1858519B1 (de) | 2005-03-12 | 2013-02-20 | Bitop Aktiengesellschaft Für Biotechnische Optimierung | Ectoin und/oder hydroxyectoin zur prophylaxe und behandlung chronisch entzündlicher darmerkrankungen |
| CN100431559C (zh) * | 2005-12-08 | 2008-11-12 | 王金政 | 一种治疗感冒的药物及制备方法 |
| CA2653773A1 (en) * | 2006-06-09 | 2007-12-21 | Parion Sciences, Inc. | Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| JP5254961B2 (ja) * | 2006-06-09 | 2013-08-07 | パリオン・サイエンシィズ・インコーポレーテッド | ベータアゴニスト活性を有するフェニル置換ピラジノイルグアニジンナトリウムチャネル遮断薬 |
| CA2663041A1 (en) * | 2006-09-07 | 2008-03-13 | Parion Sciences, Inc. | Method of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| DE102006056766A1 (de) | 2006-12-01 | 2008-06-05 | Bitop Ag | Verwendung von kompatiblen Soluten |
-
2007
- 2007-08-27 DE DE102007040615A patent/DE102007040615A1/de active Pending
-
2008
- 2008-08-25 AU AU2008291302A patent/AU2008291302B2/en active Active
- 2008-08-25 AT AT08801690T patent/ATE514422T1/de active
- 2008-08-25 WO PCT/EP2008/006959 patent/WO2009027069A2/de not_active Ceased
- 2008-08-25 DK DK11004754.5T patent/DK2380569T3/da active
- 2008-08-25 ES ES15189573T patent/ES2902827T3/es active Active
- 2008-08-25 CA CA2942021A patent/CA2942021C/en active Active
- 2008-08-25 HU HUE11004754A patent/HUE043920T2/hu unknown
- 2008-08-25 TR TR2019/08270T patent/TR201908270T4/tr unknown
- 2008-08-25 PT PT11004754T patent/PT2380569T/pt unknown
- 2008-08-25 EP EP11004754.5A patent/EP2380569B1/de active Active
- 2008-08-25 PL PL11004754T patent/PL2380569T3/pl unknown
- 2008-08-25 ES ES08801690T patent/ES2370955T3/es active Active
- 2008-08-25 EP EP08801690A patent/EP2200603B1/de active Active
- 2008-08-25 JP JP2010522237A patent/JP2010536904A/ja active Pending
- 2008-08-25 PL PL08801690T patent/PL2200603T3/pl unknown
- 2008-08-25 CA CA2698135A patent/CA2698135C/en active Active
- 2008-08-25 KR KR1020107005254A patent/KR101638637B1/ko not_active Expired - Fee Related
- 2008-08-25 ES ES11004754T patent/ES2730106T3/es active Active
- 2008-08-25 US US12/675,264 patent/US8765691B2/en active Active
- 2008-08-25 EP EP15189573.7A patent/EP3006022B1/de active Active
- 2008-08-25 EP EP18203610.3A patent/EP3482755A1/de not_active Withdrawn
- 2008-08-25 PL PL15189573T patent/PL3006022T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2200603B1 (de) | 2011-06-29 |
| ES2730106T3 (es) | 2019-11-08 |
| HUE043920T2 (hu) | 2019-09-30 |
| EP2200603A2 (de) | 2010-06-30 |
| PL2380569T3 (pl) | 2019-09-30 |
| WO2009027069A2 (de) | 2009-03-05 |
| EP3006022A1 (de) | 2016-04-13 |
| EP2380569B1 (de) | 2019-03-13 |
| EP2380569A2 (de) | 2011-10-26 |
| ES2902827T3 (es) | 2022-03-30 |
| KR20100075435A (ko) | 2010-07-02 |
| DK2380569T3 (da) | 2019-06-17 |
| DE102007040615A1 (de) | 2009-03-05 |
| ES2370955T3 (es) | 2011-12-26 |
| KR101638637B1 (ko) | 2016-07-11 |
| US20110053896A1 (en) | 2011-03-03 |
| JP2010536904A (ja) | 2010-12-02 |
| CA2942021C (en) | 2020-11-03 |
| TR201908270T4 (tr) | 2019-06-21 |
| CA2698135A1 (en) | 2009-03-05 |
| US8765691B2 (en) | 2014-07-01 |
| ATE514422T1 (de) | 2011-07-15 |
| WO2009027069A3 (de) | 2009-04-30 |
| EP2380569A3 (de) | 2012-06-27 |
| PL2200603T3 (pl) | 2011-12-30 |
| AU2008291302B2 (en) | 2014-03-20 |
| AU2008291302A1 (en) | 2009-03-05 |
| PT2380569T (pt) | 2019-06-25 |
| CA2942021A1 (en) | 2009-03-05 |
| CA2698135C (en) | 2016-11-08 |
| EP3006022B1 (de) | 2021-10-13 |
| EP3482755A1 (de) | 2019-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2200603T3 (pl) | Osmolity do leczenia alergicznych chorób oddechowych | |
| MX2013013809A (es) | Dispositivos expandibles con revestimiento de una composicion de paclitaxel. | |
| JP2010132695A5 (pl) | ||
| CA2474479A1 (en) | Composition for inhalation | |
| EP2108390A3 (en) | Device for local and/or regional delivery employing liquid formulations of therapeutic agents | |
| PH12013501790B1 (en) | Use of dpp iv inhibitors | |
| WO2013019830A3 (en) | Microfluidic drug delivery devices | |
| WO2005058935A3 (en) | Aqueous suspensions of ciclesonide for nebulisation | |
| WO2009048594A3 (en) | Multicomponent bioactive intravaginal ring | |
| JP2007513993A5 (pl) | ||
| NO20083683L (no) | Nebulisatorformulering | |
| WO2008148573A3 (de) | Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen | |
| BRPI0509026A (pt) | formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução | |
| KR20170033925A (ko) | 항바이러스 및 세균용 스프레이 조성물 | |
| WO2010042701A3 (en) | Corticosteroid compositions for use in treating diseases of the upper and lower airway passages | |
| PL2165704T3 (pl) | Zastosowanie alweryny w leczeniu dolegliwości skórnych | |
| MX2013013808A (es) | Dispositivos expandibles con revestimiento de una composicion de rapamicina. | |
| WO2008046407A3 (de) | Verwendung von deuteriumdioxid zur behandlung von hyperproliferativen erkrankungen der haut | |
| WO2009047788A3 (en) | Topical composition containing the combination of mupirocin and beclomethasone | |
| NZ597657A (en) | Use sulphur particles less than 300 microns and sodium lignin sulfonate for treating diseases casused by microbial pathogenic infections | |
| WO2007035879A3 (en) | Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm | |
| WO2005099720A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis | |
| WO2007066151A3 (en) | Topical compositions for treatment of respiratory disorders | |
| WO2011046385A3 (ko) | 감기 치료기 | |
| NO20074767L (no) | Anvendelse av rimonabant for fremstilling av medikamenter som kan anvendes i forebygging og behandling av type 2 diabetes |